HUTCHMED (China) (HCM) Consolidated Net Income (2015 - 2021)
HUTCHMED (China)'s (HCM) quarterly Consolidated Net Income came in at -$115.5 million in Q2 2021, down 832.2% year-on-year from $15.8 million in Q2 2020, and down 89.5% on a QoQ basis from -$61.0 million in Q1 2021.
HUTCHMED (China) (HCM) Consolidated Net Income (2015 - 2021) Analysis & Trends
HUTCHMED (China) (HCM) has 6 years of Consolidated Net Income data on file, last reported at -$115.5 million in Q2 2021.
- On a quarterly basis, Consolidated Net Income fell 832.2% year-over-year to -$115.5 million in Q2 2021; TTM through Dec 2022 was -$115.5 million, a 34.54% increase from a year earlier, with the FY2025 full-year figure at $64.4 million, up 836.98% from the prior year.
- Consolidated Net Income for Q2 2021 stood at -$115.5 million, down from -$61.0 million in the prior quarter.
- Over the last five years, Consolidated Net Income for HCM reached as high as $70.1 million in Q2 2018 and fell as low as -$115.5 million in Q2 2021.
- Historically, Consolidated Net Income has averaged -$12.1 million across 4 years, with a median of -$4.8 million in 2018.
- Across the five-year window, Consolidated Net Income surged 250.63% in 2019 and plunged 832.2% in 2021, its largest moves.
- Year by year, Consolidated Net Income stood at $22.1 million in 2018, then soared by 183.6% to $62.7 million in 2019, then tumbled by 74.82% to $15.8 million in 2020, then plunged by 832.2% to -$115.5 million in 2021.
- Per Business Quant data, the three most recent Consolidated Net Income figures were -$115.5 million in Q2 2021, -$61.0 million in Q1 2021, and $15.8 million in Q2 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.24 Bn | 87.37 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.91 Bn | 32.17 Bn | 1.97 Bn | 370.00 Mn |
| 3 | Zoetis | 32.61 Bn | 30.67 Bn | 1.62 Bn | 601.00 Mn |
| 4 | Takeda Pharmaceutical | 27.55 Bn | 23.49 Bn | 4.39 Bn | -3.58 Bn |
| 5 | United Therapeutics | 23.28 Bn | 21.13 Bn | 648.10 Mn | 274.90 Mn |
| 6 | RedHill Biopharma | 20.54 Bn | 20.54 Bn | - | - |
| 7 | Viatris | 20.31 Bn | 18.50 Bn | 1.16 Bn | 176.40 Mn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 197.90 Mn |
| 9 | Elanco Animal Health | 12.55 Bn | 12.12 Bn | 785.00 Mn | 57.00 Mn |
| 10 | HUTCHMED (China) | 9.57 Bn | 9.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | -115.53 Mn |
| Mar 31, 2021 | -60.97 Mn |
| Jun 30, 2020 | 15.78 Mn |
| Mar 31, 2020 | -30.28 Mn |
| Dec 31, 2019 | 62.66 Mn |
| Sep 30, 2019 | -34.24 Mn |
| Jun 30, 2019 | -99.44 Mn |
| Mar 31, 2019 | 33.60 Mn |
| Dec 31, 2018 | 22.09 Mn |
| Sep 30, 2018 | 12.78 Mn |
| Jun 30, 2018 | 70.12 Mn |
| Mar 31, 2018 | -22.31 Mn |
| Jun 30, 2016 | 29.56 Mn |
| Jun 30, 2015 | 23.49 Mn |